Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
Sheharyar Raza, Transfusion Medicine Specialist at Sunnybrook Health Sciences Center and Internal Medicine Physician at Unity Health Toronto, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Multiple Sclerosis and Related Disorders, adding:
”Plasma Exchange is a life-saving therapy that replaces patient plasma with donor plasma or derivatives.
While reasons to transfuse plasma are generally shrinking for many indications (because we now produce more specialised products for most diseases), PLasma EXchange (PLEX) is growing and remains indispensable. Many patients requiring PLEX will need large volumes of plasma or derivatives over multiple sessions administered by highly specialized nurses, and can develop serious disability or die without it. Despite being medically necessary, PLEX is only accessible at a select few, large centers in most countries, leading to delayed or non-treatment.
We performed an analysis of 52000 patients with Multiple Sclerosis captured in ICES and found that PLEX use has increased 3-fold over the last 3 decades, with a potential signal that it may be less available to patients presenting to rural hospitals.
Access publication lead by Manav Vyas, Katerina, et al.”
Title: Therapeutic Plasma Exchange in People with Multiple Sclerosis: A Province-Wide Study
Authors: Manav V. Vyas, Sheharyar Raza, Karl Everett, Tomi Odugbemi, Amirah Momen, Foad Taghdiri, Jiming Fang, Dalia Rotstein, Jiwon Oh, Katerina Pavenski

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering
-
Aug 13, 2026, 16:07Jackie Kunzler: Accelerating Innovation in Blood Processing
-
Aug 13, 2026, 16:02Pablo Corral: Is Inflammation Really a Therapeutic Target in Atherosclerosis
-
Aug 13, 2026, 15:47Breck Gamel: Why Factor V Leiden Matters
-
Aug 13, 2026, 15:25Douglas Tavares: Clinical Strategies to Reduce Blood Transfusion and Donor Reliance
-
Aug 13, 2026, 15:21Naghmeh N.: Freeze Dried Plasma Could Transform Emergency Trauma Care
-
Aug 13, 2026, 15:20W. Alberto Sifuentes Giraldo: Targeting the JAK-STAT Pathway in Behçet’s Disease